150 related articles for article (PubMed ID: 34371485)
1. Self-assembling combretastatin A4 incorporated protamine/nanodiamond hybrids for combined anti-angiogenesis and mild photothermal therapy in liver cancer.
Li Y; Lu J; Deng X; Wang X; Jia F; Zhong S; Cui X; Pan Z; Shao L; Wu Y
Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34371485
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of a phototheranostic nanoplatform for single laser-triggered NIR-II fluorescence imaging-guided photothermal/chemo/antiangiogenic combination therapy.
Lu F; Sang R; Tang Y; Xia H; Liu J; Huang W; Fan Q; Wang Q
Acta Biomater; 2022 Oct; 151():528-536. PubMed ID: 35970478
[TBL] [Abstract][Full Text] [Related]
3. Multicomponent-assembled nanodiamond hybrids for targeted and imaging guided triple-negative breast cancer therapy
Cui X; Deng X; Liang Z; Lu J; Shao L; Wang X; Jia F; Pan Z; Hu Q; Xiao X; Wu Y; Sheng W
Biomater Sci; 2021 May; 9(10):3838-3850. PubMed ID: 33885068
[TBL] [Abstract][Full Text] [Related]
4. A multifunctional nanodiamond-based nanoplatform for the enhanced mild-temperature photothermal/chemo combination therapy of triple negative breast cancer via an autophagy regulation strategy.
Cui X; Liang Z; Lu J; Wang X; Jia F; Hu Q; Xiao X; Deng X; Wu Y; Sheng W
Nanoscale; 2021 Aug; 13(31):13375-13389. PubMed ID: 34477743
[TBL] [Abstract][Full Text] [Related]
5. Auto-fluorescent polymer nanotheranostics for self-monitoring of cancer therapy via triple-collaborative strategy.
Shao L; Li Q; Zhao C; Lu J; Li X; Chen L; Deng X; Ge G; Wu Y
Biomaterials; 2019 Feb; 194():105-116. PubMed ID: 30590240
[TBL] [Abstract][Full Text] [Related]
6. p38 MAPK, but not ERK1/2, is critically involved in the cytotoxicity of the novel vascular disrupting agent combretastatin A4.
Quan H; Xu Y; Lou L
Int J Cancer; 2008 Apr; 122(8):1730-7. PubMed ID: 18074350
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of Multi-Stimuli Responsive Fe
Li Y; Kong J; Zhao H; Liu Y
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838772
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma.
Wang Y; Yu H; Zhang D; Wang G; Song W; Liu Y; Ma S; Tang Z; Liu Z; Sakurai K; Chen X
Acta Biomater; 2019 Jul; 92():229-240. PubMed ID: 31100462
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
10. Polyaniline-grafted nanodiamonds for efficient photothermal tumor therapy.
Ahn GY; Yun TH; Park J; Lee MJ; Choi I; Ryu TK; Na K; Choi SW
Colloids Surf B Biointerfaces; 2019 Aug; 180():273-280. PubMed ID: 31059985
[TBL] [Abstract][Full Text] [Related]
11. Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101.
Bao X; Shen N; Lou Y; Yu H; Wang Y; Liu L; Tang Z; Chen X
Theranostics; 2021; 11(12):5955-5969. PubMed ID: 33897892
[TBL] [Abstract][Full Text] [Related]
12. A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor.
Liu T; Zhang D; Song W; Tang Z; Zhu J; Ma Z; Wang X; Chen X; Tong T
Acta Biomater; 2017 Apr; 53():179-189. PubMed ID: 28167300
[TBL] [Abstract][Full Text] [Related]
13. Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma.
Zhao B; Dong Z; Liu W; Lou F; Wang Q; Hong H; Wang Y
J Nanobiotechnology; 2021 May; 19(1):124. PubMed ID: 33933077
[TBL] [Abstract][Full Text] [Related]
14. Ce6-Modified Carbon Dots for Multimodal-Imaging-Guided and Single-NIR-Laser-Triggered Photothermal/Photodynamic Synergistic Cancer Therapy by Reduced Irradiation Power.
Sun S; Chen J; Jiang K; Tang Z; Wang Y; Li Z; Liu C; Wu A; Lin H
ACS Appl Mater Interfaces; 2019 Feb; 11(6):5791-5803. PubMed ID: 30648846
[TBL] [Abstract][Full Text] [Related]
15. Biocompatible chitosan-carbon nanocage hybrids for sustained drug release and highly efficient laser and microwave co-irradiation induced cancer therapy.
Guo Y; Chen Y; Han P; Liu Y; Li W; Zhu F; Fu K; Chu M
Acta Biomater; 2020 Feb; 103():237-246. PubMed ID: 31843717
[TBL] [Abstract][Full Text] [Related]
16. pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma.
Wang Y; Chen H; Liu Y; Wu J; Zhou P; Wang Y; Li R; Yang X; Zhang N
Biomaterials; 2013 Sep; 34(29):7181-90. PubMed ID: 23791500
[TBL] [Abstract][Full Text] [Related]
17. Antimetastasis and antitumor efficacy promoted by sequential release of vascular disrupting and chemotherapeutic agents from electrospun fibers.
Luo X; Zhang H; Chen M; Wei J; Zhang Y; Li X
Int J Pharm; 2014 Nov; 475(1-2):438-49. PubMed ID: 25218185
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional WS
Zhang C; Yong Y; Song L; Dong X; Zhang X; Liu X; Gu Z; Zhao Y; Hu Z
Adv Healthc Mater; 2016 Nov; 5(21):2776-2787. PubMed ID: 27717238
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of Poly Dopamine@poly (Lactic Acid-Co-Glycolic Acid) Nanohybrids for Cancer Therapy via a Triple Collaboration Strategy.
Li Y; Gao Y; Pan Z; Jia F; Xu C; Cui X; Wang X; Wu Y
Nanomaterials (Basel); 2023 Apr; 13(9):. PubMed ID: 37176991
[TBL] [Abstract][Full Text] [Related]
20. Targeted polymeric micelle system for delivery of combretastatin A4 to tumor vasculature in vitro.
Wang Y; Yang T; Wang X; Wang J; Zhang X; Zhang Q
Pharm Res; 2010 Sep; 27(9):1861-8. PubMed ID: 20559700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
